Edgewell Personal Care Company (EPC) Earnings Call Transcript & Summary
May 6, 2026
Earnings Call Speaker Segments
Chris Gough
executiveHello, everyone, and thanks for being with us today for Edgewell's earnings call covering the second quarter of fiscal year 2026. Joining me are Rod Little, who serves as our President and Chief Executive Officer, and Fran Weissman, our Chief Financial Officer. Rod will get things started, and after that he'll pass it to Fran, who will go over what we delivered in Q2 2026 along with our outlook for the whole of fiscal 2026. After that, we'll open it up for questions. A recording of this call is being made, and a replay will be accessible through our site, www.edgewell.com. On this call, we might share statements regarding what we expect for upcoming plans and performance. This might relate to upcoming revenue, profits, spending on ads and promotions, rollouts of new products, money put into brands, how the company and its operations are set up and run, steps to cut expenses and boost productivity, the savings and costs associated with restructuring and repositioning, buying or selling businesses and merging them in, the effects of tariffs and other newer events like the Middle East conflict, shifts in our working capital measurements, swings in currency values, what we pay for commodities, energy and shipping expenses, inflation, the value of our categories, upcoming intentions for giving capital back to shareholders, the sale of our Feminine Care business, and much more. Any remarks of this nature qualify as forward-looking statements under the safe harbor protections established by the Private Securities Litigation Reform Act of 1995, and they represent how we presently see upcoming events, plans, or prospects. Statements like these are built on assumptions and come with a range of risks and uncertainties, among them the ones laid out beneath the heading Risk Factors in our annual report on Form 10-K covering the fiscal year that closed September 30, 2025, which could be updated in the quarterly reports we file with the SEC on Form 10-Q. Keep in mind that actual outcomes could differ substantially from what our forward-looking statements suggest or imply. We're under no duty to refresh or amend any such statements because of fresh developments or situations, unless the law demands it. During today's call, we'll mention some non-GAAP financial metrics. Such metrics aren't put together following generally accepted accounting principles. You can find a reconciliation linking those non-GAAP metrics to the closest equivalent GAAP metrics in the press release we put out earlier today, which you can access through the Investor Relations portion of our site. These non-GAAP figures are meant to accompany—not replace or take precedence over—financial performance metrics calculated under GAAP. Still, management feels these non-GAAP metrics give investors useful insight into the fundamental direction of our business and enable better comparisons of continuing operating results from one period to the next. Keep in mind that our numbers for this quarter include 1 month of the Feminine Care business, which is categorized as discontinued operations. Earlier periods have been restated to align with this presentation. The Feminine Care business's results appear separately from continuing operations. Everything we say today about results and future expectations, unless we note otherwise, will be based on continuing operations, which takes in our Wet Shave, Sun and Skin Care business. Having said that, I'll hand things over to Rod.
Rod Little
executiveThanks, Chris, and good morning to all of you. We're glad you could be with us on this call covering the second quarter of fiscal '26. Our second quarter came in strong, with results on both the top and bottom lines surpassing what we had anticipated, which speaks to the steps we've taken to reinforce the business, sharpen how we execute, and bring forward innovation that consumers are connecting with. Thanks to that top line momentum, combined with a healthy gross margin showing and rigorous execution, we were able to post adjusted earnings per share and adjusted EBITDA that came in above our guidance. What matters here is that these numbers demonstrate ongoing advancement in carrying out our strategy, putting resources behind the categories and markets where our competitive edge is unmistakable. And that is becoming visible through better consumption and market share results, the United States included. Outside the U.S., we keep posting solid market share results throughout our major markets; here at home, we generated speeding-up consumption growth along with share gains in both value and volume terms. Aggregate U.S. value share climbed roughly 50 basis points during the quarter, with increases recorded in branded manual shave, shave preps, Grooming, Sun Care and skin care. For the company, this marks a significant turning point, since we anticipate shifting to a growth profile over the back half of the fiscal year. Even as the environment remains uncertain, we are carrying out 4 priorities that we believe will fuel our near-term results as well as our longer-term strategy; those priorities are international markets, innovation, productivity and our U.S. transformation. How we direct capital and attention revolves around these priorities, as we steer resources toward the places where investment, better execution and the strongest returns are most tightly connected; you can see this focus in our simpler, higher quality portfolio, which carries a stronger margin profile following the Fem Care divestiture that closed in February. We're proceeding with the flexibility to place investments in categories where we think we hold global scale, obvious competitive advantages and momentum. Those are Wet Shave, Sun and Skin Care and Grooming. We've also become more balanced by region, with about half our sales coming from North America and half from international markets. Looking inside the portfolio, Wet Shave accounts for roughly 60% of our sales now, while our Sun, Skin Care and Grooming businesses together are nearing 40% of total sales, and Grooming alone is now above 10% of the business. With all that as background, allow me to update you on how we're doing against each of our 4 priorities. First, durable international growth. During the quarter we returned to growth, with good underlying consumption and market share trends continuing broadly across nearly every key market. Although slower first half sales came down to timing and phasing effects relative to last year, we think we're now set up for robust sales growth over the rest of the fiscal year. Second, compelling innovation. We stay dedicated to providing consumer-led, locally designed innovation throughout our portfolio. The investments we made during fiscal '25 are now set to pay off. Back then, Billie was expanded into Australia, Bulldog moved into premium skin care throughout Europe, and we brought Schick into premium skin care in Japan by launching Progista. CREMO's assortment also got wider in both the U.S. and Europe, which produced solid growth. The rest of fiscal '26 has us just as enthusiastic. Our second-half innovation lineup is strong, covering Hydro and Intuition relaunches in Japan, fresh Wilkinson Sword and Hawaiian Tropic rollouts in Europe, plus substantial introductions in Grooming and Sun Care within the U.S. Taken together, these efforts underscore how central innovation is to what we're doing strategically. Underpinning all of it is a major increase in A&P spending, directed at the brands and markets showing the tightest connection among investment, distribution gains, household penetration and repeat rates. Third, productivity through supply chain optimization. Our productivity plan is being carried out steadily and with real urgency. During this quarter, gross productivity savings came to about 220 basis points. Such moves matter a great deal to our profit profile, easing tariff and inflationary pressure, streamlining the organization, boosting speed and service levels, and freeing up capacity to put back behind our core brands; progress continues on the Wet Shave manufacturing consolidation, a key program for simplifying our footprint, modernizing shave technologies and capabilities, and strengthening the structural economics of the business. Phase 1, which folds the first 2 plants — mainly serving private label — into our new greenfield site, is almost finished and counts as the most operationally complex part of the whole effort. During this transition, we remain clear on our priorities: safeguard customer service, keep products on shelf, and limit disruption for retail partners. To hold service levels up, we're putting money into protecting fill rates, which in certain instances means running duplicate sites for longer than originally intended and also absorbing elevated operating costs like overtime and extra airfreight. Importantly, the program is still on track to achieve the service outcomes and savings we intended. Once steady state arrives, savings should start showing up in fiscal '27, reaching a full run rate in fiscal '28, which works out to about 2 points of anticipated gross margin improvement across the company. Fourth, our U.S. commercial transformation. Organizationally, we've streamlined our U.S. structure to cut complexity and speed up decision-making, with new leadership installed and clear accountability throughout our commercial teams. We're also funding core capabilities, insights and analytics, media and content, category development and revenue growth management. We expect this to sharpen how we execute at shelf alongside our retail partners and win with consumers. These steps are already producing results, as the better consumption and market share trends we see today demonstrate. We've also acted decisively to raise investment in our 5 U.S.-focused brands: Schick, Billie, Hawaiian Tropic, Banana Boat and CREMO, moving toward more sustained brand building and a balanced full funnel marketing mix. You should anticipate an increase in spending during the latter half of this fiscal year. Not long ago, we rolled out fresh campaigns and backing for Billie and CREMO, plus a brand-new Schick master brand effort called Do Right By Your Skin Campaign, which features Nick Jonas, along with our first Banana Boat campaign in 5 years. These all illustrate the larger, higher-impact full funnel campaigns we are taking to market, with support arriving shortly on Hawaiian Tropic as we move into sun season in the Northern Hemisphere. The fresh Schick campaign hones our emphasis via a skin first approach that views shaving as the opening step in skin care. This draws on our heritage and know-how in hair removal while redefining the category through a skin-first lens. Such campaigns extend the work we have completed to pinpoint consumer needs at a more granular level, fueling sharper brand positioning and elevating the bar on disruptive creative, full funnel and omnichannel excellence, delivered via our recently restructured marketing team and our new fully integrated agency partner. Going forward, ongoing support on our core brands will be paired with sharper insights, greater emphasis on innovation and renovation and continued pursuit of excellence in revenue growth management and omnichannel execution to fuel our growth.
Rod Little
executiveLooking ahead, we anticipate that these moves will reinforce our underlying health and put us in a position to grow over the longer horizon within the U.S. Turning to what's left of fiscal '26, we're restating the outlook we laid out beneath the surface for that fiscal year. The second quarter and first half results have given us reason for optimism, along with the strides being made throughout the company, and that lifts our conviction about hitting our plan. That said, the macro backdrop is uncertain, and most of our Sun Care season still lies in front of us. As a result, we're keeping a balanced and disciplined view. Risk on the whole has risen since the last time we updated you, because of the conflict in the Middle East. Although the ranges stay where they were, we detect a slight added risk on the top line, especially in our Middle East markets, plus greater inflation exposure, above all tied to oil and increased fuel expenses. Even so, a well-balanced collection of opportunities and levers remains available throughout the business to counter these added headwinds. That's the reason our confidence in steering through such items holds, and why we're at ease keeping our adjusted ranges. This confidence rests on the strategy covered earlier: durable international growth, persuasive innovation, productivity and supply chain optimization, and our U.S. commercial transformation. Let me restate the main underlying assumptions baked into this outlook. One, we anticipate a return to organic net sales growth, powered by robust second half growth in international markets and a resumption of growth in North America as our U.S. initiatives keep gaining traction through the back half of the fiscal year. Two, a step-up in brand and A&P investment is part of our plan, above all within the United States, to back our commercial transformation and speed up our key brands; our belief is that this spending, alongside our innovation pipeline, will bolster consumer response and fuel greater consumption and market share as time goes on. Three, we anticipate gross margin expansion, aided by productivity gains, pricing actions and tariff mitigation work that should accumulate as we progress into the back half of the fiscal year, partly countering inflationary headwinds. Four, while investing for the longer term, we plan to keep prioritizing adjusted free cash flow generation via working capital improvement and restrained spending. In line with that approach, our near-term capital allocation priorities stay centered on reinforcing the balance sheet, above all by directing proceeds from the Fem Care sale toward paying down our revolver balance during this quarter. Naturally, the strength of our team and our capacity to execute at a high level underpin all of this. The strides achieved this quarter bolster our belief in our plan and raise our confidence about getting back to solid, sustainable growth starting in the back half of our fiscal year, while widening margins and cash flow in a manner that creates long-term shareholder value. Having said that, I'll now hand things over to Fran, who will take you through what we achieved and what we expect for fiscal '26. Fran?
Francesca Weissman
executiveThanks, Rod. Like Rod explained, we're happy with how we performed to finish the first half of the fiscal year, with top line results that beat expectations and gross margin performance that came in as expected. On top of that, we're more and more encouraged by the better consumption numbers and the market share results for our brands, which show the ongoing progress we're making with our focused strategies. As we move toward growth in half 2, backed by additional investments in our brands, we feel confident in our ability to carry out our plan, though we stay aware of the dynamic environment we're operating in. Before we go further, I want to note that about one month of Fem Care shows up in discontinued operations within this quarter's figures. Turning to continuing operations, organic net sales declined 240 basis points during the quarter, a result that beat our forecast, as stronger-than-anticipated Grooming and branded Wet Shave performance was outweighed by the declines we had penciled in for Sun Care, reflecting order timing shifts into Q1, along with private label Wet Shave. In North America, organic net sales were down 4.8%, with volume softness in Sun Care and Wet Shave the main driver, partially countered by Grooming's double-digit increase and slight gains in Skin. International organic net sales rose 1%, as growth in Wet Shave was partly offset by declines in Sun Care and Grooming. Importantly, we achieved growth in several of our key markets. As we pivot to growth in half 2, we're encouraged by our market share performance. We've grown or held market share in nearly 80% of our markets, which is up from approximately 70% in Q1. Wet Shave organic net sales declined less than 1%, as gains in men's and women's systems were more than offset by declines in disposables and prep. International Wet Shave grew 3.6%, mainly driven by volume growth, reflecting continued category health, solid distribution outcomes and strong in-market activation. In North America, Wet Shave was down 6%, and that reflects ongoing pressure in both the category and the channel environment. Within the U.S. razor and blades category, consumption fell 130 basis points during the quarter. Overall, our value share slipped 10 basis points, which is actually better than what we saw in Q1. At the same time, our branded share rose 40 basis points, with Billie leading the way — it kept gaining share, up 40 basis points — while the rest of our brands maintained their share. Organic net sales for Sun and Skin Care dropped about 4.5%, which was caused by the expected phasing in Sun Care I mentioned earlier, though growth in Grooming and Skin partly made up for it. In the U.S., consumption for the Sun Care category was up roughly 17% for the quarter. We picked up 180 basis points of value share, thanks to higher volume for Hawaiian Tropic, though that was partly offset by modest softness in Banana Boat. In Grooming, organic net sales were up roughly 6%, with CREMO climbing about 38% and offsetting anticipated decreases among the remaining brands. Wet Ones posted organic net sales growth of around 1%, while its value share stood at about 65%. Now on to the P&L: adjusted gross margin declined 310 basis points, in line with our expectations. On the productivity side, we captured savings of about 220 basis points. However, that benefit was more than offset by several headwinds: core inflation and tariffs cost us 420 basis points, an unfavorable mix plus promotional levels net of pricing took off 70 basis points, and currency movements that went against us subtracted another 40 basis points. Looking ahead, we still expect productivity, our tariff mitigation work and pricing to strengthen through the remainder of the year, which should deliver an increase in gross margin rate for the full year versus fiscal '25. Turning to A&P, it represented 11.3% of net sales, down from 11.6% in the prior year, driven primarily by when promotional activation occurred. Looking ahead, we continue to anticipate that spending will increase across the rest of the year, funding the new campaign launches Rod walked through earlier. On an adjusted basis, SG&A represented 20.1% of net sales, up from 19.6% during the same period last year. That increase came mainly from greater consulting and corporate costs, plus unfavorable currency effects, though lower people costs provided some offset. Adjusted operating income was $49.4 million, equal to 9.5% of net sales, down from $66 million, or 12.8% of net sales, in the prior-year period. The decline primarily reflected weaker gross margins and higher SG&A expenses, with reduced A&P partially cushioning the impact. GAAP diluted net earnings per share from continuing operations was $0.09, compared with $0.43 in the second quarter of fiscal '25. For continuing operations, adjusted EPS landed at $0.60, down from $0.69 a year earlier. Currency headwinds shaved $0.04 off adjusted EPS in the quarter. Adjusted EBITDA reached $73.8 million, a figure that absorbs a $2.7 million hit from unfavorable currency, versus $84.7 million in the same quarter last year. Over the first 6 months of fiscal '26, operating activities used $71.6 million in net cash, compared with $70.5 million a year ago, driven largely by weaker earnings. Keep in mind that our cash flow figures cover both continuing and discontinued operations on a consolidated basis. Share repurchases during the quarter totaled approximately $16 million. During the quarter, we maintained our regular quarterly dividend, announcing a payout of $0.15 for each share in Q2, which distributed roughly $7 million back to investors; in total, shareholder returns for the period reached $23 million. Turning to fiscal year 2026 guidance: as Rod mentioned, we're holding steady on our foundational projections for the year, because results from the first half and ongoing advancement on our strategic goals have bolstered our assurance in carrying out the plan. Even so, we're keeping in mind the unpredictable economic environment and the reality that the bulk of the sun season is yet to come. Given all that, let me take you through what we're projecting for fiscal '26 and speak to a few important pieces behind the savings we anticipate during the year. For organic net sales, the range stays exactly where we set it in our prior outlook. Striping out currency tailwinds, we look for organic net sales to land somewhere between a 1% decline and a 2% gain. For the back half, our forecast rests on International posting mid-single-digit growth, aided by innovation and ongoing share gains across our main markets, whereas North America should strengthen and rise low single digits once our commercial programs pick up steam; Q3 should still stand out as our biggest sales quarter, driven by higher sun shipments and seasonal patterns, though we stay aware that weather and in-season demand may shift how things land by quarter. Turning to Q3, we anticipate net sales rising somewhere between 2% and 3%. Now on adjusted gross margin. On a constant currency basis, the gross margin rate accretion we project has not changed. As reported, gross margin accretion is now expected to widen by 50 basis points, a reduction of 10 basis points stemming from unfavorable FX. We look for gross margin expansion in half 2, matching our earlier commentary, as pricing actions, tariff mitigation efforts and productivity initiatives hit full run rate. Near-term pressure on inflation is coming from oil price spikes and other operating costs tied to protecting service levels, and we are addressing it via productivity, volume absorption and mix management, with those levers weighted unusually toward Q4.
Francesca Weissman
executiveLooking at how things phase out, we anticipate Q3 adjusted gross margin landing between 44% and 45%, which is a step up sequentially from the second quarter. Q4 should come in as the year's best gross margin quarter, helped by tariffs annualizing, our productivity and mitigation efforts hitting full run rate, better capacity utilization, and cycling past last year's onetime headwinds. For the full year, our A&P rate compared to last year should rise 70 basis points, which matches what we said previously. Like Rod noted, we're moving to put more investment behind our 5 U.S. focused brands: Schick, Billie, Wine Tropic, Banana Boat and CREMO. When you look at phasing, we moved spend out of Q2 and into Q3 to back the timing of our brand campaign launches, and we see Q3 as the fiscal year's biggest A&P quarter, coming in at 15% to 16% of net sales. Adjusted EPS is still the same as our prior outlook. We expect adjusted EPS between $1.70 and $2.10. This outlook takes into account expected share repurchases, which got done in the second quarter to offset current dilution, and it assumes an effective tax rate of 22% to 23%. Adjusted EBITDA is also unchanged from the previous outlook, expected between $245 million and $265 million. Because of the phasing impacts I just covered, we anticipate generating roughly 40% to 45% of second half adjusted EBITDA and adjusted EPS during the third quarter. Our adjusted free cash flow expectations, excluding the cash impacts of the Fem Care divestiture, stay the same at $80 million to $110 million for the year, and that includes expected improvements in working capital. Keep in mind, adjustments tied to the Fem Care divestiture cover taxes related to the sale, working capital and deal-related expenses. Fiscal '26 is the peak year for capital and investment spending connected to our plant consolidation and the broader supply chain transformation. This program has a set timeframe, it's not open-ended. And once we get past fiscal '26, we expect capital intensity to come down as the new footprint reaches steady state. At the same time, we expect benefits to build via improved service, lower unit costs and better working capital efficiency. Now on leverage. We expect our balance sheet to keep getting stronger as the year goes on, reflecting our new lower debt position and supported by accelerating operating cash generation and disciplined capital deployment. For full year fiscal '26, we expect adjusted net debt leverage to finish the year between 3.3x and 3.5x, which includes an estimated 0.3 to 0.4 negative turn impact from temporary Fem care divestiture timing and related items. The leverage ratio is temporarily higher during this transition period because net debt reflects our post-close balance sheet, including cash balances impacted by working capital and other items related to our divested Fem care business, while EBITDA excludes discontinued operations. In the short run, that gap gives the ratio a boost for a while, and it doesn't reflect what our earnings can really do. And to wrap up, we're staying the course on allocating capital in a disciplined way. Once taxes and deal expenses are taken out, the money we netted from selling Fem Care has gone toward making our balance sheet stronger and paying down debt, while still funding ongoing investment in our main brands through capital expenditures meant to fuel innovation and productivity. If you want more details on our fiscal '26 outlook, please see the press release we put out earlier today. With that, I'll hand things over to the operator so we can begin the Q&A.
Nik Modi
analystRob, I've got a clarification question — how much inflation do you figure you'll need to counter because of the situation in the Middle East? Could you help us frame that and put a number on it? But even more than that, I'd really like to understand your thinking on the guidance. There are simply so many moving parts. Clearly, a lot happened during the quarter. A lot is happening around the globe. And I'm looking at it more concretely — like flights being cancelled abroad, which could hurt tourism due to fuel shortages, and that could hurt Sun Care. Then there's inflation for consumers with gas prices over the summer, which might limit their ability to buy Sun Care products and other items throughout your portfolio. So I see quite a bit of added headwind on the way. Yet the fact that you're reaffirming guidance makes me want to dig into that, and hopefully you can break it down for us.
Rod Little
executiveNik, I appreciate the questions. I'll begin with the broader guidance picture, and then Fran can address the inflation we expect from Middle East activity for this year and, I suppose, offer a view toward next year too, even though that's very early — Fran can cover both. So here's how I see it: looking at our guidance for this year, we're at the halfway mark, correct? And at the halfway point we're where we expected to be, combining quarter 1 and quarter 2. That's the first point. We're keeping our outlook for the fiscal year guide on every element, as you noted. A few things are happening, I think. To start, even with the added headwinds hitting us, we adopted a more balanced planning posture overall; so our plan carried greater flexibility and more levers in case we encountered some added headwinds, which is what we're seeing now. So the headwinds we're facing — oil, commodities, the cost side — and then, as you're noting, that question of consumer demand, I can't predict where it lands, but it's on our minds; and then the cost levers meant to offset it, we've been working those hard, and that's part of why we aren't changing our guide even as we absorb some of that added cost. We have offsets elsewhere. Crucially, we're keeping our A&P stance unchanged. We aren't reducing brand investment, and we aren't reducing A&P to make this work. It's other productivity efforts, it's overhead efficiencies, and making some difficult decisions there. But the one thing I'd highlight that gives us optimism and confidence about delivering the guide is the step-up in sales rates during the second half, correct? We now have accelerating consumption and market share data in the U.S. As you can all observe in the scanner data, we've had 26 weeks in a row of volume share increases, and in the U.S. that growth is speeding up. Fran mentioned that 80% of our global category country combinations are either maintaining or gaining market share; that's the strongest spot we've ever been in. So momentum across the business is broad-based. Distribution is now locked in, correct, through the planogram resets. So that's in place as we anticipated. On international, we've discussed throughout the year that phasing would lean more toward a second-half plan. To illustrate, Shave outside the U.S. in Q2 came in at 4%. The phasing was mostly in Sun Care, lower in the first half, higher in the second half. And we have new campaigns plus new innovation all rolling out with added investment supporting them; and the content is genuinely, genuinely strong, quite different from before when you look at what we're putting out and how we're connecting with consumers. One last figure for you: April has begun well. We're observing the step-up we anticipated during April, which of course just ended for us, consistent with this guide we've issued; so that step-up is indeed occurring. So the last point before I hand it to Fran regarding balance. Look, I think your comments about flights being canceled, travel possibly threatened for certain tourism markets in the second half due to higher oil or perhaps jet fuel unavailable in some situations. We have visibility into those risks. We believe we're equally balanced against what has been a solid start to the domestic sun season here, with the category up double digits. Us ahead of that, gaining market share from a consumption standpoint. And we haven't altered our outlook for the year, partly since 80% of the seasons remain ahead. We don't know what the weather will bring, but we think those 2 elements, the international tourism risk, the possible domestic upside, we think that's balanced on the whole, and that's part of what supports our thinking. Fran, do you want to add anything there and then address the inflation piece?
Francesca Weissman
executiveYeah. Thank you, Rod. I'll tackle this in two pieces. When we look at fiscal '26 and what's happening in the Middle East, obviously, the situation hasn't fully played out yet. But the piece we can see clearly, and the piece we've put numbers against for '26, comes to roughly $3 million to $5 million, and it hits us primarily on margin. We're facing some top line pressures across Middle East markets, as you'd expect. That's already baked into what we've guided for Q3. And inside the gross margin rate, we're seeing near-term cost increases tied to W&D and certain commodities. The bulk of that ends up sitting in inventory. So if this keeps going, additional pressures will show up during '27. We haven't put a size on that yet, but our best guess, based on where things stand today, is likely similar in scale to what we projected for tariffs, which we've more than offset during this year thanks to our productivity initiatives. Looking ahead to '27, though, it matters that we have solid mitigation levers. We expect productivity to pick up pace, particularly given the consolidation of our plants. We're also staying focused on FRGM and on managing mix. And even more significantly, pricing will serve as a lever, naturally, one we'll weigh — both targeted pricing and, where it makes sense, inflationary pricing. So '27 is still coming into focus, and we'll share more once we know it. But that represents our best visibility given what we know right now.
Chris Carey
analystI have a quick follow-up about inflation and gross margin, then I want to ask something about North America. On inflation — unless I've calculated this incorrectly — fiscal Q4 shows a very large step-up, whether you look at it as an absolute percentage or as a shift versus the prior year. You just walked everyone through it, and I understand tariffs are lapping while productivity is accumulating, but even so, that's a substantial figure. So I was hoping you might go a little deeper, specifically on how confident you are about that gross margin, and about your sense that you keep making the right calls for the business. Then on the North America side, is there any way to consider what the underlying growth rates were there during the quarter if we adjust for when Sun Care shipments landed, plus the improvement you're assuming the business will see in the back half of the year?
Rod Little
executiveFran, you cover inflation and gross margin, and I'll handle North America.
Francesca Weissman
executiveOkay, so whenever we look at the back half, we've consistently expected the bulk of our earnings—specifically two-thirds—to land there. But now that the first half is behind us, the actual figure is shaping up to be nearer to 60%. A significant driver of that was stronger sales results, along with better gross margin results. I'd separate gross margin into two distinct buckets. There's a sequential gain in Q3, though we've always known Q4 would be our biggest quarter, and that's for two clear reasons. First, what we're up against from the prior year. You might remember there were one-time, transitory items that landed disproportionately on us during Q4. That accounts for roughly half of the Q4 step-up, plus tariff mitigation is running at full rate, and on top of that, we're annualizing tariffs in Q4 too; so that's pushing Q4 disproportionately to come in a bit above what Q3 shows. Then the final component is simply productivity efforts. We've pinpointed and locked in our productivity efforts for the year. A larger share of that is landing in Q4 since, as you're aware, we hold more than 120 days of inventory. So a portion of this ends up stuck. The encouraging part, though, is that we can already see it coming. So the way it's playing out is just disproportionately weighted toward July and August rather than June. Those are the primary drivers behind the results, and it's genuinely consistent with what we'd anticipated. Rod, would you like to walk through it?
Rod Little
executiveSure thing, Chris — regarding North America, I believe you've identified exactly where that turning point sits. During the opening six months, and especially across the April-to-June stretch, Sun declined roughly 10% for that period, which mostly mirrors a mismatch in the timing between what we shipped versus what actually moved off shelves, plus those comparisons against the prior-year window, which tend to be unpredictable when you're looking quarter to quarter. Sun will swing to growth, correct, over the back six months. In fact, our guidance has the whole North American region climbing by a low single-digit rate across that latter half. So that's the reversal for Sun, and once consumption data starts reflecting that shift, Sun goes into positive territory. Grooming remains a strong performer for us. As we mentioned, CREMO climbed 38% during the quarter that just wrapped. That trajectory carries into the latter half. Beyond that, Wet Shave results are actually getting better on a relative comparison against how things stood in Q2; this comes from improved distribution results as well as what we consider genuinely powerful campaigns. Take the Do Right By Your Skin Campaign we rolled out for Schick last week featuring Nick Jonas — it has connected with shoppers and driven engagement beyond what we anticipated; so we feel upbeat about every part of the portfolio. Plus, from a commercial standpoint in North America, we're now better positioned for this business to keep delivering growth than at any point in the last 2 to 3 years. Ultimately, that represents the major turning point for our business, both for the remaining half of this year and as we move ahead into '27. So we're feeling confident about the second half, Chris.
Susan Anderson
analystI suppose this is more of a follow-up regarding that top line growth. So, how are you all feeling about retail inventory out there, and specifically, I mean, clearly the sellouts have been quite robust? Do you have a good level of confidence that retailers are going to have to replenish because of that strength? And then as you start rolling out these new launches, whether that's Hawaiian Tropic or Wet Shave in Europe, I believe you mentioned Japan, are you picking up any pipes or additional shelf space that we ought to be thinking about that would also assist in driving that top line? Also, maybe you could share your perspective on how the promotional landscape in Wet Shave looks for the second half.
Rod Little
executiveSure. Susan, I'll take the first part of that question, and Fran can speak to the competitive dynamics and the assumptions we've baked in. From where I sit, the back half looks really well positioned for us, since we aren't aware of any retailer inventory stocking issues. As a matter of fact, in a lot of cases with our brands, we think retailer inventory levels ought to be higher; and going into this period, the trade is quite balanced. We're aware that certain regions genuinely require replenishing stock levels. Sun serves as a solid illustration of this. Demand for our product has grown faster than the overall market, and that category has performed well — honestly, it exceeded what we had anticipated when we looked at the first six months. As a result, we should see that translate into sell-through during the back half. Even in the absence of favorable weather conditions, I believe our positioning sets us up to deliver on the commitments we've outlined. Also, nothing major is slated for launch in the latter part of the year on the innovation front, so there shouldn't be any imbalance or issues carrying into the following year. Still, in plenty of instances, we picked up additional shelf presence through our distribution results, and that, I believe, not only makes us confident about hitting our second-half targets, but also builds momentum as we look toward fiscal '27 and the planograms coming in the next year, given the velocities and consumption figures we're seeing. On Japan, which you brought up — correct, we secured more shelf space there in branded shape. That's a branded market, so private label is basically absent, though preps are also a factor. Right now, Japan is showing substantial expansion for us in preps, and the reason behind that is a shift toward a more regimen-based approach there, which historically may not have represented much of the business. So that side of things is growing, and a large share of it comes from distribution. Over in Europe, we picked up meaningful distribution wins, landing some tenders in private label shaving, and we also captured shelf space gains for Shave and Sun. In the U.S., we've already talked about the added gains we're seeing across the whole Wet Shave category, covering both branded and grooming. The biggest distribution strides have mostly come from CREMO in grooming, particularly body wash and APDO. We believe that is something we can maintain, and it continues through 2027.
Francesca Weissman
executiveRight, and to add to that point, when we look at those distribution gains, on the previous call we discussed how important half 2 was, along with the growth profile, distribution, and planogram resets being included in that; we've now wrapped that up, and they're landing as expected. So many of those distribution gains are already baked into our half 2 outlook. And on promotional intensity, the level we're seeing remains the same as what we've been seeing. It's baked into our outlook. It isn't higher than what we expected. And I'd say we're seeing slightly more intensity, naturally, in women's shave, but again, broadly consistent with what we'd already expected and factored into our promotional plans for the rest of the year.
Olivia Tong Cheang
analystCould you give us some benchmarks for the coming year as opposed to only the back half? You brought up 120 days on inventory, which clearly shifts a lot of the elevated costs we're seeing out of the second half. You also brought up certain mitigation choices available to you, such as the possibility of inflation-driven pricing. So should we take it that gross margin takes a bigger hit in fiscal '27 than in the second half of fiscal '26? Maybe you could give us benchmarks on commodities and on what your suppliers are telling you regarding how fast costs are inflating? Then the second part of my question concerns pricing and promotion. Clearly, the environment has been pretty difficult on the promotional side; so have you noticed any recent shifts in how your competitors are promoting, and can you offer some confidence about your capacity to possibly take some targeted pricing at some point during the coming year?
Rod Little
executiveOlivia, I'll begin and Fran can chime in if she has anything to add. Look, obviously we can't discuss '27 in terms of guidance. But looking ahead past the back half of the year, we know we have certain cost productivity levers we've discussed that are larger than usual. We expect the coming year to be a solid cost productivity year for us as we begin to capture the first savings tranche from the shave manufacturing piece, correct? So we have, I believe, a solid line of sight to cost productivity efforts regarding cost of goods and margin that carries on past the second half. We won't size or quantify that. What we also know is that in the back half of this year, there are some onetime items in the base that won't carry into '27, and those make that Q4 gross margin Fran mentioned earlier outsized in terms of the increase versus the prior period. And so I think we're in a more normalized range where I won't predict that we grow gross margin at this point next year. We won't guide to that, but we have levers that, as we finalize our plans, should let us do that, correct? We ought to be able to pull those levers that way. The one piece I'll mention as we move forward that's somewhat different and unknown right now, with this level of elevation, franchise it as our — what we have line of sight to now concerns what the gross tariff impact was on us a year ago, which we largely offset through cost productivity. I would expect that we'd have some pricing power and some capacity to take pricing if this elevated oil commodities basket stays where it is today, because everyone is affected by that. What's fascinating on our end is the current shape of the company—if you take out Fem Care and look at the fresh lineup, 75% of what we run is either expanding or keeping share from a really solid spot. That leaves 25% sitting in the U.S. shave bucket, which happens to be the area where we've fallen behind. Whether pricing is even possible in that bucket, I can't say, though when it comes to international shave and sun skin grooming, given the stronger equity we now enjoy and how competition tends to behave there, my expectation is that should these inflated commodity rates persist, we'd be considering some price increases in the coming year. To be clear, no specific size or pledge attaches to that—still, it's certainly one lever we'd examine for next year. And honestly, that option simply isn't available to us at the same level during this year. Looking organically at how sales grow heading into next year, I'd say the back half should signal what's ahead for '27, especially as we consider releasing guidance within the coming 5 to 6 months. We aren't there yet. The back half ought to serve as a decent stand-in for sales growth. Fran, anything to add? No. Alright.
Rod Little
executiveOkay, that’s everything. Thanks to all of you. We’re grateful that you keep following Edgewell, and we’ll speak once more in early August when we report our Q3 results. Enjoy the summer.
Operator
operatorThat brings us to the end of this call. We appreciate your joining us for today's presentation. At this point, you're free to disconnect.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Edgewell Personal Care Company transcript — plus 133,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Edgewell Personal Care Company earnings transcripts and 133,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Edgewell Personal Care Company or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.